Banner

Lupus Nephritis Video Perspectives

Healio spoke with Michelle A. Petri, MD, MPH, director of the John Hopkins Lupus Center, about lupus nephritis treatment approaches, patient populations most likely to develop lupus nephritis, unmet needs of patients with lupus nephritis and more.

Michelle A Petri, MD, MPH

Video Player is loading.
Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
    • Chapters
    • descriptions off, selected
    • captions off, selected
      1. Now Playing
        Up NextPetri2NEW
      2. Now Playing
        Up NextPetri1FINAL
      3. Now Playing
        Up NextPetri3FINAL
      4. Now Playing
        Up NextPetri4NEW
      5. Now Playing
        Up NextPetri5NEW
      6. Now Playing
        Up NextPetri6NEW
      7. Now Playing
        Up NextPetri7NEW
      8. Now Playing
        Up NextPetri8NEW

      In this video, Michelle A. Petri, MD, MPH, director of the Johns Hopkins Lupus Center, discusses the following:

      • treatment options, including changes in treatment protocols, and a breakdown of different classes of lupus nephritis;
      • what is in the pipeline for lupus nephritis, including two new FDA approved therapies;
      • treatment approaches for patients at risk of developing lupus nephritis or with existing lupus nephritis and the disease classes;
      • challenges in treating the different classes of lupus nephritis and the importance of early detection;
      • patient populations more likely to develop lupus nephritis and the increase in deaths from lupus nephritis;
      • unmet needs of patients with lupus nephritis and racial disparities in these deaths; and
      • outcome expectations for patients with lupus nephritis.